Back to TRDA

CITADEL ADVISORS LLC → TRDA

CITADEL ADVISORS LLC TRDA Position History

Entrada Therapeutics, Inc. • Healthcare

Quarters held
8
Latest value
$1.2M
Q3 2026
Peak value
$2.4M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$1.7M
Q1 2026$965K
Q2 2026$551K
Q2 2026$2.4M
Q2 2026$551K
Q2 2026$2.4M
Q3 2026$1.7M
Q3 2026$1.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.2M191.9K——
Q3 2026$1.7M269.8K——
Q2 2026$2.4M319.5K——
Q2 2026$551K74.9K——
Q2 2026$2.4M319.5K——
Q2 2026$551K74.9K——
Q1 2026$965K76.5K——
Q1 2026$1.7M138.5K——

Other funds holding TRDA

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B